Description
RADIOPHARMACEUTICALS
First action · last action
2020-10-01 · 2021-11-04
Transactions
3
First transaction's obligation
$366,007
Base + all options value (sum of deltas)
$278,495
Extent competed
COMPETED UNDER SAP
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
VA25917D0328
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 3 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2020-10-01+$366,007= $366,007
- Mod P000012021-03-19-$60,000= $306,007
- Mod P000022021-11-04-$27,512= $278,495
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2020-10-01 | +$366,007 | $366,007 | RADIOPHARMACEUTICALS |
| Mod P00001· FUNDING ONLY ACTION | 2021-03-19 | −$60,000 | $306,007 | RADIOPHARMACEUTICALS |
| Mod P00002· FUNDING ONLY ACTION | 2021-11-04 | −$27,512 | $278,495 | RADIOPHARMACEUTICALS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI GY8NMUZQXVS7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926P0013 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $358,454 | FY2026 |
| 36C25926N0074 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $435,690 | FY2026 |
| 36C25925P0724 | NETWORK CONTRACT OFFICE 19 (36C259) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $35,984 | FY2025 |
| 36C24E25C0002 | RPO EAST (36C24E) · AJ14 · GENERAL SCIENCE & TECHNOLOGY R&D SVCS; GENERAL SCIENCE & TECHNOLOGY; R&D ADMINISTRATIVE EXPENSES | $39,502 | FY2025 |
| 36C25925N0026 | NETWORK CONTRACT OFFICE 19 (36C259) · 6505 · DRUGS AND BIOLOGICALS | $429,877 | FY2025 |
| 36C26224P1817 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · R410 · SUPPORT- PROFESSIONAL: PROGRAM EVALUATION/REVIEW/DEVELOPMENT | $24,950 | FY2024 |
Other recipients under 6505 from NETWORK CONTRACT OFFICE 19 (36C259) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25926F0310 | JANSSEN BIOTECH INC | NETWORK CONTRACT OFFICE 19 (36C259) | $384,719 | FY2026 |
| 36C25926N0409 | MEDI-PHYSICS, INC. | NETWORK CONTRACT OFFICE 19 (36C259) | $34,735 | FY2026 |
| 36C25926F0264 | JANSSEN BIOTECH INC | NETWORK CONTRACT OFFICE 19 (36C259) | $384,719 | FY2026 |
| 36C25926N0384 | SIRTEX MEDICAL INC | NETWORK CONTRACT OFFICE 19 (36C259) | $245,194 | FY2026 |
| 36C25926P0553 | COSETTE PHARMACEUTICALS, INC. | NETWORK CONTRACT OFFICE 19 (36C259) | $3,439 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25921N0054_3600_VA25917D0328_3600 · retrieved 2026-09-26.